Trials / Unknown
UnknownNCT05532527
Efficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective Study
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 35 (estimated)
- Sponsor
- Henan Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
To evaluate the efficacy and safety of microwave ablation combined with Camrelizumab and chemotherapy in the treatment of patients with advanced non-small cell lung cancer.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Microwave ablation combined with Camrelizumab and chemotherapy | Microwave ablation combined with Camrelizumab and chemotherapy |
Timeline
- Start date
- 2022-09-20
- Primary completion
- 2023-09-20
- Completion
- 2025-09-20
- First posted
- 2022-09-08
- Last updated
- 2022-09-08
Source: ClinicalTrials.gov record NCT05532527. Inclusion in this directory is not an endorsement.